2nd Apr 2007 12:22
Ark Therapeutics Group PLC02 April 2007 ARK THERAPEUTICS GROUP PLC 2 April 2007 Annual Information Update Ark Therapeutics Group plc (the "Company") is pleased to provide an annualinformation update in accordance with the requirements of Prospectus Rule 5.2.This update refers to information that has been published or made available bythe Company to the public in the 12 months up to and including 30 March 2007. The following UK regulatory announcements have been made via the Regulatory NewsService provided by the London Stock Exchange: Date Headline 28 March 2006 Annual Information Update30 March 2006 Agreement27 April 2006 Placing and Open Offer27 April 2006 Results of Annual General Meeting19 May 2006 Re Placing and Open Offer22 May 2006 Directors' Shareholdings26 May 2006 Director Share Dealing5 June 2006 Blocklisting Interim Review9 June 2006 Holding(s) in Company21 June 2006 Agreement27 June 2006 Holding(s) in Company7 July 2006 US Patent for Vitor13 July 2006 Holding(s) in Company4 August 2006 Notice of Results23 August 2006 Research Update30 August 2006 Interim Results1 September 2006 Cerepro EMEA Review5 September 2006 Research Update8 September 2006 Holding(s) in Company27 September 2006 Research Update2 October 2006 Holding(s) in Company10 October 2006 Kerraboot13 October 2006 Cerepro Patent Granted27 November 2006 Holding(s) in Company4 December 2006 Blocklisting Interim Review4 December 2006 Blocklisting Interim Review14 December 2006 Placing of Shares18 December 2006 Holding(s) in Company20 December 2006 Voting and Rights Capital20 December 2006 Holding(s) in Company5 January 2007 Research Update11 January 2007 Research Update15 January 2007 Award19 January 2007 Notice of Results22 January 2007 Total Voting Rights25 January 2007 Holding(s) in Company1 February 2007 European Grant Awarded5 February 2007 Option Awards6 February 2007 Holding(s) in Company16 February 2007 Research Update16 February 2007 Holding(s) in Company22 February 2007 Stroke Patent23 February 2007 Holding(s) in Company1 March 2007 Voting Rights and Capital5 March 2007 Holding(s) in Company7 March 2007 Final Results12 March 2007 Holding(s) in Company15 March 2007 Holding(s) in Company19 March 2007 Block Listing Application30 March 2007 Holding(s) in Company Copies of all regulatory announcements for Ark Therapeutics Group plc can befound on the Press Release Archive page on the Company's websitewww.arktherapeutics.com The Ark Therapeutics Group plc Annual Report 2006 and the Interim Report 2006were filed on 26 March 2007 and 5 September 2006 respectively at the UKLADocument Viewing Facility, Financial Services Authority, 25 The Colonnade,Canary Wharf, London E14 5HS. These documents are also available on theCompany's website www.arktherapeutics.com or on application to the CompanySecretary. A Placing and Open Offer prospectus was filed at the UKLA Document ViewingFacility, Financial Services Authority, 25 The Colonnade, Canary Wharf, LondonE14 5HS on 27 April 2006. This document is available upon application to theCompany Secretary. The Company has also made the following filings at Companies House: Date of Filing Document filed 27 April 2006 Resolutions passed at Annual General Meeting2 May 2006 Amended Articles of Association8 June 2006 Return of Allotment of Shares11 September 2006 Return of Allotment of Shares19 September 2006 Return of Allotment of Shares28 September 2006 Return of Allotment of Shares28 September 2006 Return of Allotment of Shares2 October 2006 Return of Allotment of Shares3 October 2006 Return of Allotment of Shares6 November 2006 Return of Allotment of Shares6 November 2006 Return of Allotment of Shares12 January 2007 Return of Allotment of Shares29 January 2007 Return of Allotment of Shares2 February 2007 Return of Allotment of Shares9 February 2007 Return of Allotment of Shares28 February 2007 Return of Allotment of Shares28 February 2007 Return of Allotment of Shares16 March 2007 Return of Allotment of Shares19 March 2007 Return of Allotment of Shares26 March 2007 Return of Allotment of Shares Copies of these documents can be obtained from Companies House, Crown WayMaindy, Cardiff CF14 3UZ or through Companies House Direct atwww.direct.companieshouse.gov.uk. Further information is available regarding the Company and its activities on itswebsite www.arktherapeutics.com. The information referred to in this update was up to date at the time theinformation was published, but some information may now be out of date. Enquiries: Ark Therapeutics Group plc 020 7388 7722Nick Plummer, Company Secretary This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PVG.L